Bayer Aktiengesellschaft is trading 5.2% down at €33.30 after fresh uncertainty emerged regarding its proposed $7.25 billion U.S. Roundup weedkiller settlement.
- Plaintiffs are seeking to transfer the planned settlement to a different federal court, raising concerns about potential delays or changes to the deal.
- This renewed litigation risk is weighing on investor sentiment and driving the latest leg of declines in the company's volatile share price.